Product Information
GLYXAMBI 25 MG-5 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $11.1996 per EA under NDC 00597016430. Its NADAC has been published 584 times since Apr 22, 2015.
Strength
25; 5 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597016430
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMPAGLIFLOZIN; LINAGLIPTINApproval Type
New Drug (NDA)
FDA Application
NDA206073On Market Since
1/30/2015
Pharmacological Classes
Price Statistics
The NADAC for GLYXAMBI 25 MG-5 MG TABLET has been published 584 times since Apr 22, 2015, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1996 per EA |
|---|---|
| All-time high | $20.1302 (May 14, 2025) |
| All-time low | $11.1925 (Jan 7, 2026) |
| 52-week high | $20.1289 |
| 52-week low | $11.1925 |
| Median price | $17.2893 |
| Average price | $17.4440 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 584 |
| Tracking since | Apr 22, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLYXAMBI 25 MG-5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYXAMBI 25 MG-5 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $11.1996 per EA (NDC 00597016430), effective Jun 24, 2026.
How has the price of GLYXAMBI 25 MG-5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYXAMBI 25 MG-5 MG TABLET has declined 23.4%. It has been tracked across 584 weekly CMS publications since Apr 22, 2015.
What are the highest and lowest recorded NADAC prices for GLYXAMBI 25 MG-5 MG TABLET?
Since Apr 22, 2015, the NADAC for GLYXAMBI 25 MG-5 MG TABLET has ranged from a low of $11.1925 (Jan 7, 2026) to a high of $20.1302 (May 14, 2025), with a median of $17.2893 per EA.
Are there cheaper alternatives to GLYXAMBI 25 MG-5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as GLYXAMBI 25 MG-5 MG TABLET, but none are currently priced below it.
Who manufactures GLYXAMBI 25 MG-5 MG TABLET?
GLYXAMBI 25 MG-5 MG TABLET (NDC 00597016430) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification